{"nct_id":"NCT02132754","title":"Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)","status":"COMPLETED","status_verified_date":"2021-01","start_date":"2014-06-27","start_date_type":"ACTUAL","primary_completion_date":"2019-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2019-07-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}